Cephalosporins — Cefotaxime 10 years later, a major drug with continued use
| Autor: | H. C. Neu |
|---|---|
| Rok vydání: | 1991 |
| Předmět: |
Microbiology (medical)
Drug medicine.medical_specialty Time Factors Cefotaxime medicine.drug_class medicine.medical_treatment media_common.quotation_subject Urinary system Cephalosporin Antibiotics Microbial Sensitivity Tests Gram-Positive Bacteria beta-Lactamases Spontaneous bacterial peritonitis Internal medicine Gram-Negative Bacteria medicine Humans media_common Chemotherapy business.industry Drug Resistance Microbial Bacterial Infections General Medicine medicine.disease Cephalosporins Surgery Infectious Diseases business Meningitis medicine.drug |
| Zdroj: | Infection. 19:S309-S315 |
| ISSN: | 1439-0973 0300-8126 |
| DOI: | 10.1007/bf01715770 |
| Popis: | Cefotaxime has in the past decade proved to be a most useful agent. It has established the efficacy and safety suggested in the early in vitro, pharmacological and clinical papers. It remains an excellent agent to treat many community and hospital-acquired respiratory infections, urinary tract infections, meningitis, particularly in pediatrics, spontaneous bacterial peritonitis and selected abdominal and gynecological infections. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink